FDA approves new psoriasis drug (FDA - Food and Drug Administration)
(World News Science)

(Source: FDA - Food and Drug Administration) The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or injected) or phototherapy (ultraviolet light treatment) and have failed to respond, or have stopped responding to other systemic therapies. `Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today`s approval provides patients with another treatment option for...